QCI Asset Management Inc. NY raised its stake in shares of Transcat, Inc. (NASDAQ:TRNS) by 10.0% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 24,587 shares of the scientific and technical instruments company’s stock after buying an additional 2,226 shares during the period. QCI Asset Management Inc. NY owned about 0.35% of Transcat worth $299,000 as of its most recent filing with the SEC.

Separately, Neuberger Berman Group LLC boosted its stake in shares of Transcat by 3.1% in the second quarter. Neuberger Berman Group LLC now owns 164,993 shares of the scientific and technical instruments company’s stock valued at $2,005,000 after buying an additional 4,900 shares during the last quarter. 56.24% of the stock is currently owned by institutional investors and hedge funds.

Shares of Transcat, Inc. (NASDAQ TRNS) opened at 12.85 on Tuesday. The firm’s 50-day moving average is $12.86 and its 200 day moving average is $12.26. Transcat, Inc. has a 52 week low of $10.00 and a 52 week high of $14.05. The firm has a market capitalization of $91.61 million, a PE ratio of 20.40 and a beta of 0.34.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Tuesday, July 25th. The scientific and technical instruments company reported $0.12 EPS for the quarter. The firm had revenue of $36.28 million during the quarter. Transcat had a return on equity of 10.37% and a net margin of 3.03%. On average, equities analysts forecast that Transcat, Inc. will post $0.64 earnings per share for the current year.

WARNING: This piece was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/29/qci-asset-management-inc-ny-increases-position-in-transcat-inc-trns.html.

Separately, Dougherty & Co started coverage on shares of Transcat in a research note on Wednesday, August 23rd. They set a “buy” rating and a $20.00 price objective for the company.

In related news, Director Paul D. Moore sold 4,000 shares of the company’s stock in a transaction on Friday, August 4th. The stock was sold at an average price of $13.00, for a total transaction of $52,000.00. Following the completion of the transaction, the director now directly owns 57,698 shares in the company, valued at approximately $750,074. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Carl E. Sassano sold 7,500 shares of the company’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $13.02, for a total value of $97,650.00. Following the transaction, the director now owns 79,075 shares of the company’s stock, valued at $1,029,556.50. The disclosure for this sale can be found here. Over the last 90 days, insiders have purchased 2,081 shares of company stock valued at $24,924. 8.80% of the stock is owned by company insiders.

About Transcat

Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS).

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Stock Ratings for Transcat Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat Inc. and related stocks with our FREE daily email newsletter.